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A tumorigenic 
culprit in ES cells
 
n the debate over whether ES cells or 
somatic stem cells have better prospects 
for stem cell therapies, ES cell proponents 
admit that their pluripotent cells carry an 
increased risk: ES cells can form teratomas. 
But now Kazutoshi Takahashi, Kaoru 
Mitsui, and Shinya Yamanaka (Nara 
Institute of Science and Technology, 
Nara, Japan) have found that a newly 
discovered Ras gene may be at the heart 
of this problem.
ERas, previously thought to be a 
pseudogene, was found by the group 
as being expressed specifically in ES cells. 
The other genes in this expression class 
are also expressed in early embryonic tissues 
such as the inner cell mass and epiblast, 
but no expression of ERas is evident in 
the embryo. The lack of phenotype of 
ERas knockout mice adds to the mystery.
Yamanaka suggests that ERas may be 
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WASPs with memory
 
emory may not be confined to brain cells. Eduardo 
Torres and Michael Rosen (University of Texas South-
western Medical Center, Dallas, TX) have found that the 
actin polymerization activator WASP has at least the potential 
to be a memory device. Such a capacity could switch cells 
into an altered state in which they respond more acutely to 
a stimulus the second time around.
Rosen was intrigued initially by the location of a tyrosine 
in WASP that others had found was phosphorylated. In struc-
tural models, Tyr 291 is buried in the fold that forms in the 
autoinhibisted form of WASP. Sure enough, Tyr 291 could 
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In inactive WASP,
Tyr 291 (purple)
is hidden between
two domains.
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only be phosphorylated 
(thus further activating 
WASP activity) when 
the structure was opened 
up via addition of the 
activating Cdc42.
Both Tyr 291 phosphor-
ylation and Cdc42 acti-
vation can be driven by Src 
family kinases. But Cdc42 
activation and opening of WASP 
take some time, so only a 
persistent Src signal will still 
 
connected to the LIF/Stat3 pathway, which 
is dispensable for normal mouse develop-
ment but necessary in ES cells and for the 
extended survival of mouse blastocysts 
(a process called diapause). Only in the 
ES cells and during diapause must pluri-
potency be extended past a few days, and 
this extension may be helped by LIF or 
ERas expression. The situation is clouded 
further in humans and monkeys, however, 
as both have apparently functional ERas 
genes but lack diapause.
Whatever the function of ERas, “ERas 
null cells should be much safer for clinical 
applications,” says Yamanaka. ERas has 
residues characteristic of activated Ras 
proteins, and is found largely in the 
activated, GTP-bound form. Its addition 
transforms cells, whereas its deletion 
from ES cells sharply reduces their 
tumor-forming ability. Growth is also 
reduced in ERas knockout cells, but 
Yamanaka says that rich culture conditions 
largely correct for this and thus slow growth 
should not hold back the use of altered 
ES cells. Direct human applications will 
not, however, come from Yamanaka’s 
group in the foreseeable future, as there 
are extensive bureaucratic hurdles involved 
in experimentation on human ES cells 
in Japan. 
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Cells expressing ERas form tumors in mice.
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be around to phosphorylate Tyr 291 by the time it is exposed.
WASP could then act as a memory device if Src maintains 
the Tyr 291 phosphorylation until after Cdc42 is turned off 
(as might happen if a GTPase activating protein drops by and 
shuts off Cdc42). Torres and Rosen showed that this form of 
WASP clasps and protects the phosphorylation on Tyr 291 so 
it is resistant to removal by phosphatases. In contrast to the 
initial, unphosphorylated form of WASP that took such a 
sustained signal to activate, the phosphorylated WASP is 
now in a primed form. A future signal need only tickle the 
Cdc42 system to achieve full activation.
For now, the site of action of these mechanisms are 
unknown. “What we’ve found is exclusively biochemical,” 
says Rosen. “We don’t know where this will occur in vivo.” 
But, he says, “having this as the biochemical concept will 
drive the kind of work” needed to put the findings in context. 
Rosen is looking for places where later responses might be 
affected by earlier experience. The best candidate is in neurite 
outgrowth, where N-WASP phosphorylation has been seen 
to persist long after the kinase stimulus has vanished. Perhaps 
such phenomena allow neurites to keep extending even through 
areas that have temporary drops in outgrowth factors.
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